High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal Cancer
Authors:
- 1 September 1995
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 86 (9) , 847-853
Abstract
To examine whether renal cell carcinoma displays altered CD44 expression we performed reverse transcription‐polymerase chain reaction (RT‐PCR) analysis of CD44 in 38 specimens from renal cancer, normal kidney and metastases of 19 patients and 6 renal cancer cell lines. To detect the CD44 variants, we utilized the RT‐PCR Southern blot method. One out of 19 (5.3%) renal cancer specimens expressed a larger molecular weight band than 1 kb by RT‐PCR analysis, in contrast to previous findings in colon and breast cancer. The band patterns in RT‐PCR were different in 14/17 (82.4%) cases between normal kidney and tumors, and a band of about 700 bp was especially marked in 12/17 (70.6%) tumor specimens and 4/6 (66.7%) cell lines. By cloning and sequencing of the 700 bp band, we found that this variant is identical to the CD44 variant sharing only exon v10. Examination by Northern blot analysis has revealed that all tumors express a higher level of CD44 mRNA than paired normal kidneys. These findings suggested that the CD44 variants sharing exon v10 play some role in renal cancer.Keywords
This publication has 24 references indexed in Scilit:
- Expression and modulation of CD44 variant isoforms in humansJournal of Cell Biology, 1994
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Prevention of tumor metastasis formation by anti-variant CD44.Journal of Experimental Medicine, 1993
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.Journal of Cell Biology, 1993
- Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44Science, 1992
- Differential expression of the CD44 molecule in human brain tumoursInternational Journal of Cancer, 1992
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Expression of CD44 confers a new adhesive phenotype on transfected cellsCell, 1990
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.Journal of Cell Biology, 1987
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986